RE:Last NR is two weeks old.Lesalpes29 wrote: Really need an other good one. A possible deal on the viruses side? GL
"The global herpes simplex virus treatment market size was estimated at USD 2.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030." ---------------------------- "The prevalence of herpes simplex virus (HSV) infection is on the rise. According to an estimate from WHO, as of April 2023 approximately 3.7 billion people under age 50, which account for 67% of the population, are living with HSV-1 infection and an estimated 491 million people between ages 15 and 49 years are living with HSV-2 infection. Such a high number of HSV cases will require adequate therapeutic management." ------------------------------------ The increase in government funding for promoting research in HSV infection space is anticipated to drive the market growth during the forecast period. HSV is a kind of STD with limited treatment approaches; hence, governments, public & private organizations, and nonprofit organizations are granting funds to boost research activities to develop novel therapeutic approaches in HSV and other sexually transmitted diseases." ------------------------------------------- https://www.grandviewresearch.com/industry-analysis/herpes-simplex-virus-treatment-market-report